> top > docs > PMC:7029759 > spans > 5889-6461 > annotations

PMC:7029759 / 5889-6461 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
162 109-118 Species denotes 2019-nCoV Tax:2697049
163 186-194 Species denotes patients Tax:9606
164 271-280 Species denotes 2019-nCoV Tax:2697049
165 340-349 Species denotes 2019-nCoV Tax:2697049
166 374-382 Species denotes patients Tax:9606
167 557-565 Species denotes patients Tax:9606

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T36 109-118 SP_7 denotes 2019-nCoV
T35 119-124 NCBITaxon:10239 denotes virus
T34 271-280 SP_7 denotes 2019-nCoV
T33 340-349 SP_7 denotes 2019-nCoV

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T47 95-96 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T48 119-124 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T49 138-143 http://purl.obolibrary.org/obo/CLO_0009985 denotes focus
T50 176-182 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T51 472-474 http://purl.obolibrary.org/obo/CLO_0050475 denotes my
T52 546-553 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T39 0-281 Sentence denotes In this article, I will outline different potential treatment options that could be pursued as a therapy for 2019-nCoV virus, keeping the focus on agents that could be rapidly tested in patients today and broadly effective in spite of limited knowledge of the biology of 2019-nCoV.
T40 282-414 Sentence denotes Simply stated, there is limited time for basic studies of 2019-nCoV in research labs, while patients need effective therapies today.
T41 415-572 Sentence denotes I finally propose the best potential treatment option in my opinion, along with instructions on how to manufacture the therapy for testing in patients today.